178 related articles for article (PubMed ID: 37485688)
1. Impact of Median Sternotomy on Safety and Efficacy of the Subcutaneous Implantable Cardioverter Defibrillator.
Sugrue A; Ibrahim R; Lu M; Bhatia NK; Alkukhun L; Adewumi J; Schaller RD; Marchlinski FE; D'Souza B; Nazer B; Tzou W; Merchant FM; Frankel DS
Circ Arrhythm Electrophysiol; 2023 Aug; 16(8):468-474. PubMed ID: 37485688
[TBL] [Abstract][Full Text] [Related]
2. Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.
Raja J; Guice K; Oberoi M; Whitwell S; Asbeutah AA; Russell A; Khouzam RN
Curr Probl Cardiol; 2022 Sep; 47(9):100927. PubMed ID: 34311985
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
[TBL] [Abstract][Full Text] [Related]
6. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
[TBL] [Abstract][Full Text] [Related]
7. The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience.
Khazen C; Magnusson P; Flandorfer J; Schukro C
Cardiol J; 2019; 26(5):543-549. PubMed ID: 29718532
[TBL] [Abstract][Full Text] [Related]
8. Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies.
Kuschyk J; Müller-Leisse J; Duncker D; Tülümen E; Fastenrath F; Fastner C; Kruska M; Akin I; Liebe V; Borggrefe M; Veltmann C; Rudic B
Int J Cardiol; 2021 Jan; 323():100-105. PubMed ID: 32871189
[TBL] [Abstract][Full Text] [Related]
9. Multicenter assessment of the outcomes of subcutaneous ICD implantation in patients with prior or future sternotomy.
Al-Kofahi M; Adeola OG; Payne J; Mohammed M; Reddy YM; Dendi R; Pimentel R; Berenbom L; Emert M; Ramirez R; Noheria A; Montgomery JA; Sheldon SH
Pacing Clin Electrophysiol; 2023 Feb; 46(2):100-107. PubMed ID: 36355425
[TBL] [Abstract][Full Text] [Related]
10. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
[TBL] [Abstract][Full Text] [Related]
11. Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.
Nazer B; Dale Z; Carrassa G; Reza N; Ustunkaya T; Papoutsidakis N; Gray A; Howell SJ; Elman MR; Pieragnoli P; Ricciardi G; Jacoby D; Frankel DS; Owens A; Olivotto I; Heitner SB
Heart Rhythm; 2020 Jul; 17(7):1107-1114. PubMed ID: 32084597
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
[TBL] [Abstract][Full Text] [Related]
13. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of SubcutAneous implantable cardioVErter-defibrillators in ≤18 year-old CHILDREN: SAVE-CHILDREN registry.
Mori H; Sumitomo N; Tsutsui K; Fukunaga H; Hayashi H; Nakajima H; Muraji S; Nabeshima T; Kawano D; Ikeda Y; Asano S; Nitta J; Watanabe S; Hokosaki T; Sato S; Chisaka T; Higaki T; Nakajima T; Tamura S; Kaneko Y; Ikeda K; Okada A; Kobayashi H; Motoki H; Minamiguchi H; Imamura T; Shizuta S; Kawamura M; Munetsugu Y; Suzuki T; Murakami T; Horigome H; Wada T; Takamuro M; Ozawa J; Suzuki H; Izumi D; Otsuki S; Chinushi M; Kato K; Miura M; Maeda J; Fukunaga M; Kondo H; Takahashi N; Tobiume T; Morishima I; Kuraishi K; Nakamura K; Hayashi H; Suzuki H; Yoshida Y; Fukamizu S; Hojo R; Nuruki N; Yoshinaga M; Hayashi K; Fukaya H; Kishihara J; Kobayashi T; Kato R
Int J Cardiol; 2023 Jan; 371():204-210. PubMed ID: 36087632
[TBL] [Abstract][Full Text] [Related]
15. The SIDECAR project: S-IcD registry in European paediatriC and young Adult patients with congenital heaRt defects.
Silvetti MS; Bruyndonckx L; Maltret A; Gebauer R; Kwiatkowska J; Környei L; Albanese S; Raimondo C; Paech C; Kempa M; Fésüs G; Knops RE; Blom NA; Drago F
Europace; 2023 Feb; 25(2):460-468. PubMed ID: 36107451
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous implantable cardioverter defibrillator in children and adolescents: results from the S-ICD "Monaldi care" registry.
Sarubbi B; Colonna D; Correra A; Romeo E; D'Alto M; Palladino MT; Virno S; D'Onofrio A; Russo MG
J Interv Card Electrophysiol; 2022 Mar; 63(2):283-293. PubMed ID: 33709295
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis.
Araújo CS; Silva CLB; da Silva Menezes Júnior A; Barbosa VA; de Almeida Laranjeira T; Fernandes JF; Gonçalves LC; Silva AMC
Curr Cardiol Rev; 2022; 18(3):e081221198647. PubMed ID: 34879809
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.
Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J
Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
Shinohara T; Abe I; Hirota K; Kondo H; Fukui A; Akioka H; Teshima Y; Yufu K; Nakagawa M; Takahashi N
Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
